Agilent Technologies (NYSE:A) Updates Q3 2026 Earnings Guidance

Agilent Technologies (NYSE:A) updated its third quarter 2026 earnings guidance on Wednesday. The company provided earnings per share guidance of 1.480-1.500 for the period, compared to the consensus earnings per share estimate of 1.500. The company issued revenue guidance of $1.8 billion-$1.9 billion, compared to the consensus revenue estimate of $1.8 billion. Agilent Technologies also updated its FY 2026 guidance to 6.000-6.100 EPS.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on the stock. Barclays dropped their price objective on shares of Agilent Technologies from $150.00 to $140.00 and set an “overweight” rating for the company in a report on Tuesday, April 14th. TD Cowen dropped their price objective on shares of Agilent Technologies from $170.00 to $157.00 and set a “buy” rating for the company in a report on Thursday, February 26th. Wells Fargo & Company dropped their price objective on shares of Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating for the company in a report on Thursday, February 26th. Morgan Stanley dropped their price objective on shares of Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating for the company in a report on Tuesday, March 3rd. Finally, Robert W. Baird lifted their price objective on shares of Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a report on Tuesday. Two equities research analysts have rated the stock with a Strong Buy rating, twelve have given a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat, Agilent Technologies presently has a consensus rating of “Buy” and an average price target of $162.40.

Agilent Technologies Trading Up 0.6%

Shares of NYSE:A opened at $115.82 on Thursday. Agilent Technologies has a 52 week low of $108.35 and a 52 week high of $160.27. The company’s 50 day moving average is $114.99 and its two-hundred day moving average is $128.79. The company has a current ratio of 2.07, a quick ratio of 1.59 and a debt-to-equity ratio of 0.44. The company has a market cap of $32.73 billion, a PE ratio of 25.57, a P/E/G ratio of 2.42 and a beta of 1.22.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, beating analysts’ consensus estimates of $1.41 by $0.08. Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. The company had revenue of $1.84 billion for the quarter, compared to the consensus estimate of $1.80 billion. During the same period in the prior year, the firm posted $1.31 EPS. The company’s quarterly revenue was up 10.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Equities analysts predict that Agilent Technologies will post 5.95 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th will be issued a $0.255 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $1.02 annualized dividend and a dividend yield of 0.9%. Agilent Technologies’s dividend payout ratio is presently 22.52%.

Key Headlines Impacting Agilent Technologies

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent beat Q2 expectations with adjusted EPS of $1.49 versus consensus around $1.41 and revenue of $1.83 billion versus the $1.80 billion forecast, showing solid execution and 10% year-over-year sales growth. Agilent Reports Second-Quarter Fiscal Year 2026 Financial Results
• Positive Sentiment: The company raised its full-year 2026 profit outlook, citing strong demand for lab tools and research/diagnostic equipment, which supports the case for higher earnings ahead. Agilent raises 2026 profit forecast on strong demand for lab tools
• Positive Sentiment: Management’s updated FY 2026 guidance of $6.00-$6.10 EPS and $7.4 billion-$7.5 billion revenue came in slightly above Wall Street expectations, reinforcing confidence in continued growth. Agilent Reports Second-Quarter Fiscal Year 2026 Financial Results
• Neutral Sentiment: Analyst coverage remained constructive, with RBC starting coverage at Outperform and Baird lifting its price target, which adds support but is not a direct operating catalyst. Analyst coverage updates
• Negative Sentiment: Agilent’s Q3 EPS guidance of $1.48-$1.50 was only in line with, or slightly below, estimates, which may temper enthusiasm despite the stronger full-year outlook. Agilent Reports Second-Quarter Fiscal Year 2026 Financial Results

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of the stock. Fiduciary Trust Co boosted its holdings in shares of Agilent Technologies by 1.6% in the 3rd quarter. Fiduciary Trust Co now owns 4,931 shares of the medical research company’s stock valued at $633,000 after buying an additional 77 shares in the last quarter. IHT Wealth Management LLC boosted its holdings in shares of Agilent Technologies by 4.9% in the 4th quarter. IHT Wealth Management LLC now owns 2,041 shares of the medical research company’s stock valued at $278,000 after buying an additional 96 shares in the last quarter. UMB Bank n.a. boosted its holdings in shares of Agilent Technologies by 3.0% in the 4th quarter. UMB Bank n.a. now owns 4,500 shares of the medical research company’s stock valued at $612,000 after buying an additional 131 shares in the last quarter. Zions Bancorporation National Association UT boosted its holdings in shares of Agilent Technologies by 17.2% in the 4th quarter. Zions Bancorporation National Association UT now owns 990 shares of the medical research company’s stock valued at $135,000 after buying an additional 145 shares in the last quarter. Finally, Modern Wealth Management LLC boosted its holdings in shares of Agilent Technologies by 5.7% in the 2nd quarter. Modern Wealth Management LLC now owns 2,889 shares of the medical research company’s stock valued at $341,000 after buying an additional 157 shares in the last quarter.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.